A Randomized Open-Label Phase 3 Study of XL092 +Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer Monika Chaudhry | June 4, 2022
A PHASE I/Ib GLOBAL, MULTICENTER, OPEN-LABEL UMBRELLA STUDY EVALUATING THE SAFETY AND EFFICACY OF TARGETED THERAPIES IN SUBPOPULATIONS OF PATIENTS WITH METASTATIC COLORECTAL CANCER (INTRINSIC) Monika Chaudhry | June 19, 2021